Introducing our latest CRO offering for the development of cardiovascular interventions.
December 10, 2024
3
mins read
Robert Langer and Lindus Health co-founder, Meri Beckwith, sat down for a Q&A session to discuss their new partnership and future direction of the company.
January 30, 2024
Lindus Health Releases "All-in-One Cardiovascular CRO" Offering for Clinical Trials Serving Cardiovascular Health
Lindus Health Announces the Completion of Two Clinical Trials for Woebot Health’s Digital Application for Depression and Anxiety Symptoms
8/22/24
mins
Sharing recent developments from our recent trials with Woebot Health.
Lindus Health Unveils “All-in-One Dermatology CRO” Offering for Dermatology Clinical Trials
8/6/24
Introducing our "All-in-One Dermatology CRO" bespoke to dermatology clinical trials.
PILA PHARMA INKS AGREEMENT WITH LINDUS HEALTH ABOUT NEXT CLINICAL TRIAL WITH SAFETY AND OBESITY READOUTS
7/24/24
4
Announcing our Phase 2a clinical trial with PILA PHARMA to assess the tolerability, safety, and efficacy of XEN-D0501 in patients with type II diabetes and obesity.
Lindus Health and Aktiia to launch observational clinical trial for Aktiia’s Optical Blood Pressure Monitoring Device
7/9/24
We're pleased to announce the launch of our 7,500-participant trial with Aktiia!
CLEO Appoints CRO to Manage U.S. Ovarian Cancer Clinical Trials
4/11/24
2
Announcing our recent collaboration with CLEO Diagnostics for an ovarian cancer detection clinical trial.
Lindus Health Launches Bespoke “All-in-One Medical Device CRO” Offering for Medical Device Clinical Trials
6/27/24
Introducing our newest CRO, site services, and eClinical technology offering to the medical device market.